Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose stavudine versus standard-dose stavudine in virologically controlled HIV patients
2004-001403-35Phase 2Active
- Sponsor
- Pere Domingo
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of stavudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Pere Domingo. Started Jan 2006; status: active.
02
Drugs
stavudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-001403-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001403-35.